-
Journal Context: The American Journal of Surgery / PubMed | Identifiers: DOI: 10.1016/S0002-9610(00)00342-9 / PMID: 11033123
-
Principal Investigators: Mulder, G. D., Patt, L. M., Sanders, L., et al. (Wound Healing Center, University of California San Diego)
-
Methodology: A multi-center, randomized, double-blind clinical human trial evaluating 120 patients presenting with stagnant, chronic diabetic ulcers. Subject cohorts received either a topical gel containing a GHK-Cu complex or a matching placebo vehicle daily over a continuous 12-week monitoring cycle.
-
Key Findings: Patients treated with the active GHK-Cu complex demonstrated a statistically significant increase in full open-wound closure rates ($56\%$ baseline clearance) compared to only $38\%$ in the control arm ($P < 0.05$). Biopsies confirmed that the copper peptide accelerated tissue granulation, prompted rapid microvascular blood vessel sprouting (angiogenesis), and cleanly closed the wound boundary without inducing hyper-keratinized scar defects.

